¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mixed lymphocyte reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
¿µ¹® transfusion reaction ÇÑ±Û ¼öÇ÷ºÎÀÛ¿ë, ¼öÇ÷¹ÝÀÀ
¼³¸í   
  ¼öÇ÷ÇÏ¿´À» ¶§¿¡ È¯ÀÚ¿¡°Ô ÀϾ´Â ¹ÝÀÀ. ¾Ë·¹¸£±â ¹ÝÀÀ°ú ¿ëÇ÷ ¹ÝÀÀÀÌ ÀÖ´Ù.
¿µ¹® graft versus host reaction ÇÑ±Û ÀÌ½ÄÆí´ë ¼÷ÁÖ¹ÝÀÀ
¼³¸í   
  ¸é¿ªÀ̶õ ÀÚ½ÅÀÇ °Í°ú ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» ±¸ºÐÇØ¼­ ÀÚ½ÅÀÇ °ÍÀÌ ¾Æ´Ñ °ÍÀ» °ø°ÝÇÏ¿© »ý¹°ÇÐÀû È°¼ºÀ» ¾ø¾Ö°Å³ª Á¦°ÅÇϴ °ÍÀÌ´Ù. ÀÌ ¸é¿ªÀº ÁַΠÇ÷¾×¿¡ Àִ ¼¼Æ÷¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. Æ¯È÷ ¸²ÇÁ±¸´Â ÀÌ ¸é¿ª¿¡ ÁßÃßÀûÀΠ¿ªÇÒÀ» Çϴ ¼¼Æ÷ÀÌ´Ù. ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀÀ̶ó´Â °ÍÀº À̽ĵǾî¿Â Á¶Á÷¿¡ Á¸ÀçÇϴ ŸÀÎÀÇ Ç÷±¸µéÀÌ ¼÷ÁÖÀÇ ¼¼Æ÷¸¦ °ø°ÝÇϴ °ÍÀ» ¸»ÇÑ´Ù. Áï À̽ĵǾî¿Â Á¶Á÷°ú ÇÔ²² µé¾î¿Â Ç÷±¸µéÀÌ À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¼¼Æ÷¸¦ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÇϴ Çö»óÀÌ´Ù. À̰ÍÀº À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ ¸é¿ª»óŰ¡ Á¤»óÀûÀÏ °æ¿ì¿¡´Â ÀϾÁö ¾Ê´Âµ¥ ¿Ö³ÄÇϸ頸鿪»óŰ¡ Á¤»óÀÏ °æ¿ì¿¡´Â À̽ĵǾî¿Â Àå±â¿Í ´õºÒ¾î µé¾î¿Â Å¸ÀÎÀÇ Ç÷±¸µéÀ» À̽ÄÀ» ¹ÞÀº »ç¶÷ÀÇ Ç÷±¸°¡ Å¸ÀÎÀÇ °ÍÀ¸·Î ÀÎÁöÇØ¼­ °ø°ÝÀ» ÇÏ°í ¼ýÀûÀ¸·Î À¯¸®ÇÏ¿© ¸ðµÎ Á×ÀÏ ¼ö°¡ Àֱ⠶§¹®ÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sensitized lymphocyte
    ¹Î°¨È­¸²ÇÁ±¸
  • mixed acid
    È¥ÇÕ»ê
  • mixed aphasia
    È¥ÇÕ¾ð¾î»ó½ÇÁõ, È¥ÇսǾîÁõ
  • mixed astigmatism
    È¥ÇÕ³­½Ã
  • mixed beam irradiation
    È¥ÇÕºû»ìÁ¶»ç, È¥ÇÕºöÁ¶»ç
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • mixed chancre
    È¥Çձ˾ç
  • mixed connective tissue disease
    È¥ÇÕ°áÇÕÁ¶Á÷º´
  • mixed cryoglobulinemia
    È¥ÇÕÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ, È¥ÇÕÀú¿Â±Û·ÎºÒ¸°Ç÷Áõ
  • mixed culture
    ¼¯¾î½É±â, È¥ÇÕ¹è¾ç
  • mixed density
    1. È¥Çչеµ 2. È¥ÇÕÀ½¿µ
  • mixed episode
    È¥Àç»ðÈ­
  • mixed gallstone
    È¥ÇÕ¾µ°³µ¹, È¥ÇÕ´ã¼®
  • mixed germ cell tumor
    È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
  • mixed gland
    È¥ÇÕ»ù, È¥ÇÕ¼±
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cross reaction
    ±³Â÷¹ÝÀÀ
  • delayed reaction
    Áö¿¬¹ÝÀÀ
  • graft versus host reaction
    ÀÌ½ÄÆí´ë¼÷ÁÖ¹ÝÀÀ
  • inhibition reaction
    ¾ïÁ¦¹ÝÀÀ
  • initial reaction
    Ãʱâ¹ÝÀÀ
  • late reaction
    (¢¡delayed reaction) Áö¿¬¹ÝÀÀ
  • periosteal reaction
    »À¸·¹ÝÀÀ, °ñ¸·¹ÝÀÀ
  • phobic reaction
    °øÆ÷¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • reversible reaction
    °¡¿ª¹ÝÀÀ
  • second order reaction
    ÀÌÂ÷¹ÝÀÀ
  • second set reaction
    ÀÌÂ÷°ÅºÎ¹ÝÀÀ
  • setting reaction
    ÀÀ°í¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • short lived lymphocyte
    ´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
  • thymic lymphocyte
    °¡½¿»ù¸²ÇÁ±¸
  • thymus-derived lymphocyte
    °¡½¿»ùÀ¯·¡¸²ÇÁ±¸
  • monocyte lymphocyte ratio
    ´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    °¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
  • mixed acid
    È¥ÇÕ»ê
  • mixed amputation
    È¥ÇÕÀý´Ü
  • mixed aphasia
    (¢¡global aphasia) ¿ÏÀü¾ð¾î»ó½ÇÁõ
  • mixed astigmatism
    È¥ÇÕ³­½Ã
  • mixed chancre
    È¥Çձ˾ç
  • mixed cryoglobulinemia
    È¥ÇÕÇÑ·©±Û·ÎºÒ¸°Ç÷Áõ
  • mixed culture
    ¼¯¾î½É±â
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • mixed decimal
    ´ë¼Ò¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anti-lymphocyte globulin
    ¸²ÇÁ±¸ Çױ۷κҸ°
  • antigen, lymphocyte defined (LD)
    ¸²ÇÁ±¸ Ç¥¸éÇ׿ø, LDÇ׿ø
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • hodgkins disease,lymphocyte predominance
    ¸²ÇÁ±¸ ÇöÀúÇü
  • primed lymphocyte
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸
  • primed lymphocyte typing
    ÃÊȸÇ׿øÀÚ±ØÈÄ ¸²ÇÁ±¸Çüº°È­
  • primed lymphocyte-typing test
    ÃÊȸ°¨ÀÛ ¸²ÇÁ±¸ÀÌ¿ë Çüº°°Ë»ç
  • ADR : adverse drug reaction
    ¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
  • Arthuss reaction
    ¾Æ¸£Åõ½º¹ÝÀÀ
  • Cannizzaros reaction
    Ä«´ÏÂ¥·Î¹ÝÀÀ.
  • Chediaks reaction
    ¼¼µð¾ÆÅ© ¹ÝÀÀ.
  • Dische reaction
    µð½¬¹ÝÀÀ.
  • Ehrlich reaction
    ¿¡¸£¸®È÷ ¹ÝÀÀ
  • Fernandez reaction
    Æä¸£³­µ¥½º ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effector T lymphocyte
    ÀÛµ¿T¸²ÇÁ±¸
  • effector lymphocyte
    ÀÛµ¿¸²ÇÁ±¸.
  • granulocyte-monocyte-lymphocyte antigens
    °ú¸³±¸´Ü±¸¸²ÇÁ±¸Ç׿ø
  • granulocyte-platelet-lymphocyte antigens
    °ú¸³±¸Ç÷¼ÒÆÇ¸²ÇÁ±¸Ç׿ø
  • hodgkins disease,lymphocyte predominance
    ¸²ÇÁ±¸ ÇöÀúÇü
  • killer lymphocyte
    »ìÇØ¸²ÇÁ±¸
  • large lymphocyte
    ´ë¸²ÇÁ±¸(¡­Ï¹).
  • large lymphocyte
    Å«¸²ÇÁ±¸
  • large lymphocyte
    ´ë¸²ÇÁ±¸(?Ë´).
  • leukocytoid lymphocyte
    ¹éÇ÷±¸¾ç ¸²ÇÁ±¸
  • lymphocyte
    ¸²ÇÁ±¸(¡­Ï¹).
  • lymphocyte
    ¸²ÇÁ±¸
  • lymphocyte activating factor
    ¸²ÇÁ±¸È°¼ºÀÎÀÚ
  • lymphocyte activating factor (LAF)
    ¸²ÇÁ±¸ Ȱ¼ºÈ­ÀÎÀÚ
  • lymphocyte analysis
    ¸²ÇÁ±¸ºÐ¼®
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed micelle
    È¥¼º(ûèà÷)¹Ì¼¿
  • mixed surface film
    È¥ÇÕÇ¥¸é(ûèùêøúØü)Çʸ§
  • mixed triglyceride
    È¥¼º(ûèà÷)Æ®¸®±Û¸®¼¼¶óÀ̵å
  • mixed-type inhibitor
    È¥ÇÕÇü ÀúÇØÁ¦(ûèùêúþîÁúªð¥)
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
  • absolute reaction rates
    Àý´ë¹ÝÀÀ¼Óµµ (ï¾ÓßÚãëëáÜÓø)
  • abstraction reaction
    Á¦°Å¹ÝÀÀ (ð¶ËÛÚãëë)
  • Adamkiewicz reaction
    ¾Æ´ãŰºñÃ÷ ¹ÝÀÀ(Úãëë)
  • addition reaction
    ºÎ°¡¹ÝÀÀ(ݾʥÚãëë)
  • Akabori reaction
    ¾ÆÄ«º¸¸®¹ÝÀÀ(Úãëë)
  • alarm reaction
    °æÁ¾¹ÝÀÀ (Ìíñ¤Úãëë)
  • anaphylactoid reaction
    ¾Æ³ªÇʶô½Ã½º¾ç(åÆ) ¹ÝÀÀ(Úãëë)
  • anaplerotic reaction
    º¸Àü¹ÝÀÀ(ÜÍîóÚãëë)
  • annulation reaction
    ȯ»óÇü¼º ¹ÝÀÀ(ü»ßÒû¡à÷Úãëë)
  • anthrone reaction
    ¾ÈÆ®·Ð ¹ÝÀÀ(Úãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • periosteal reaction
    °ñ¸·¹ÝÀÀ
  • pyrogenic reaction
    ¹ß¿­¹ÝÀÀ
  • reaction
    ¹ÝÀÀ
  • side reaction
    ºÎÀÛ¿ë, ºÎ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MC mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med...
MLC   1) Minimal Lethal Concentration
  2) Mixed Lymphocyte Culture
AMLC adherent macrophage-like cell; autologous mixed lymphocyte culture
MLI mesiolinguoincisal; mixed lymphocyte interaction
MLTI mixed lymphocyte target interaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MLC Mixed lymphocyte culture
MLR Mixed lymphocyte reactivity
MLR Mixed lymphocyte response
MLTC Mixed lymphocyte tumor cell cultures
MLTC mixed lymphocyte tumor culture
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • atypical or mixed organic brain syndrome
    ºñÁ¤Çü ³»Áö È¥ÇÕÇü ±âÁú¼º ³ú ÁõÈıº
  • essential mixed cryoglobulinemia
    ¿ø¹ß¼º È¥ÇÕ ÇѳÃ-±Û·Îºí¸°Áõ
    µå¹® Àü½Å¼º ÁúȯÀ¸·Î¼­ IgG-IgM º¹ÇÕü°¡ ÁÖ ¼ººÐÀÎ ÇѳÃ-±Û·Îºí¸°ÀÇ Ä§ÂøÀ¸·Î ÇǺΠÇ÷°ü¿°, Ȱ¸·¿° ¹× ÃÊÁ¡¼º ³»Áö ¹Ì¸¸¼º Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ ³ªÅ¸³­´Ù. CÇü °£¿°°ú °°Àº °¨¿°¿¡ ¼Ó¹ßÇÏ´Â ÇѳÃ-±Û·Îºí¸°Ç÷Áõ¿¡¼­´Â ¸·Áõ½Ä¼º »ç±¸Ã¼ ½Å¿°ÀÌ °üÂûµÇ±âµµ ÇÑ´Ù.
  • miscible : susceptible of being mixed.

    misdiagnosis

    ¿ÀÁø
  • mixed
    È¥ÇÕÇü, È¥ÇÕÇÑ, È¥¼ºÀÇ
  • mixed color
    È¥ÇÕ »ö
  • mixed cryoglobulin syndrome
    È¥ÇÕ Çѳà ±Û·ÎºÒ¸° ÁõÈıº
  • mixed deafness
    È¥ÇÕ¼º ³­Ã»
  • mixed dental arch
    È¥ÇÕ Ä¡¿­±Ã
  • mixed dentition analysis
    È¥ÇÕ Ä¡¿­±âÀÇ ¾Ç±Ã °ø°£ ºÐ¼®
    È¥ÇÕ Ä¡¿­±â ±³ÇÕÀº ¿µ±¸ Á¦1 ´ë±¸Ä¡°¡ ¸ÍÃâÇÏ´Â 6-7¼¼ºÎÅÍ Çü¼ºµÈ´Ù. ½ÃÁø ¹× ±¸°­ ¹æ»ç¼±ÇÐÀû °Ë»çÀÇ È°¿ëÀ» ÅëÇØ ¿µ±¸Ä¡ ¸ÍÃâ ¼ø¼­¸¦ »ìÆìº¸´Â °ÍÀº Á¤»ó ±³ÇÕ Çü¼ºÀÇ °¡´É¼º ÆÇ´Ü¿¡ À¯È¿ÇÑ Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù.
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • mixed form
    È¥ÇÕ Çü
  • mixed function oxidase
    È¥ÇÕ ±â´É ¿Á½Ãµ¥À̽º
  • mixed germ cell tumors
    È¥ÇÕ ¹è¾Æ¼¼Æ÷ Á¾¾ç
  • mixed headache
    È¥ÇÕÇü µÎÅë
    ±Ù ±äÀ强 µÎÅë°ú ÆíµÎÅëÀÌ ÇÑ È¯ÀÚ¿¡¼­ ÇÔ²² ³ªÅ¸³¯ ¶§.
  • mixed mesodermal tumor
    È¥ÇÕ Á߹迱¼º Á¾¾ç, È¥ÇÕ¼º Á߹迱¼º Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mixed discrete-continuous random variable <statistics> A random variable that may assume some values with probabilities and others with probability densities.
For example, in a 35-year-old man with familial polyposis of the colon, the distribution of time until malignant disease occurs consists of a probability that he already has cancer (which would be assigned the waiting time 0), a probability density of developing it in the future and a probability that he will die of some other cause before he develops cancer.
(05 Mar 2000)
mixed disulfide <chemistry> Disulfide which is not symmetric on both sides of the -s-s- linkage; e.g., the disulfide formed between coenzyme A and glutathione or between cysteine and coenzyme A or glutathione.
Synonym: asymmetric disulfide.
(05 Mar 2000)
mixed esotropia <ophthalmology> That type of esotropia in which both accommodative and nonaccommodative factors are present.
(05 Mar 2000)
mixed expired gas <physiology> One or more complete breaths of expired gas coming thoroughly mixed from the dead space and the alveoli.
(05 Mar 2000)
mixed function oxidases <enzyme> Catalyse the insertion of one oxygen atom of molecular oxygen into the organ substrate. Require a second substrate to donate electrons for the reduction of the second atom in the oxygen molecule to water.
Registry number: EC 1.13.12.
(12 Dec 1998)
mixed gland A gland that contains both serous and mucous secretory units, a gland that is both exocrine and endocrine, e.g., the pancreas.
(05 Mar 2000)
mixed glioma <tumour> A glioma comprised of two or more malignant elements, most frequently astrocytoma and oligodendroglioma.
(05 Mar 2000)
mixed hyperlipaemia Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance.
Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia.
(05 Mar 2000)
mixed hyperlipidemia mixed hyperlipoproteinaemia familial, type 5 hyperlipidemia
mixed hyperlipoproteinaemia familial Type 5 hyperlipidemia, elevations of VLDL and chylomicrons found in plasma.
Synonym: mixed hyperlipidemia.
(05 Mar 2000)
mixed hypoglycaemia Hypoglycaemia due to more than one cause.
(05 Mar 2000)
mixed infection Infection by more than one variety of pathogenic microorganisms.
(05 Mar 2000)
mixed mesodermal tumour A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells.
Synonym: malignant mixed mullerian tumour.
(05 Mar 2000)
mixed nerve <anatomy, nerve> A nerve containing both afferent and efferent fibres.
(05 Mar 2000)
mixed opioid agonist-antagonist <pharmacology> A compound that has an affinity for two or more types of opioid receptors and blocks opioid effects on one receptor type while producing opioid effects on a second receptor type.
(13 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reaction engine
    (·ÎÄÏÀÇ)¿ªÃßÁø ¿£Áø
  • reaction formation
    ¹Ýµ¿ Çü¼º(»çȸÀû.µµ´öÀûÀ¸·Î ÁÁÁö ¾ÊÀº ¿å±¸³ª ¿ø¸ÁÀ» ¾ïÁ¦Çϱâ À§ÇÏ¿© ÀÌ ¿å±¸¿Í´Â ¹Ý´ë ¹æÇâÀÇ µ¶´ÜÀû ÇൿÀ» ÃëÇÏ´Â ¹«ÀǽÄÀû ÇàÀ§)
  • reaction shot
    ¾ó±¼¿¡ ³ªÅ¸³ª´Â ¹ÝÀÀÀ» Àâ´Â ¼ô;Ç¥Á¤ÀÇ Å¬·ÎÁî¾÷
  • reaction time
    ¹ÝÀÀ ½Ã°£
  • thermonuclear reaction
    ¿­ÇÙ ¹ÝÀÀ
  • mixed
    ¼¯ÀÎ
  • mixed
    ¼¯ÀÎ;³²³à È¥ÇÕÀÇ
  • mixed bag
    µÚ¹ü¹÷;Àâ´ÙÇÑ °Í(»ç¶÷)
  • mixed blessing
    ÀÌÇØ°¡ ¾ùºñ½ÁÇÑ °Í(ÀÏ);À¯¸®ÇÏÁö¸¸ ºÒ¸®ÇÔµµ µû¸£´Â »çÅÂ
  • mixed boat
    È­°´¼±
  • mixed chalice
    (±³È¸¿¡¼­) ÀǽĿëÀ¸·Î Æ÷µµÁÖ¿¡ ¹°À» ź ¼º¹è
  • mixed chorus
    È¥¼º ÇÕâ
  • mixed doubles
    (Å״Ͻº) ³²³à È¥ÇÕ º¹½Ä
  • mixed drink
    ÇÕ¼ºÁÖ
  • mixed economy
    (ÀÚº»ÁÖÀÇ,»çȸÁÖÀÇ º´Á¸ÀÇ)È¥ÇÕ °æÁ¦;¿µ±¹¿¡¼­ º¼ ¼ö ÀÖÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á